TY - STD TI - World Population Prospects. The 2015 revision, key findings and advance tables: United Nations; 2015. http://www.un.org/en/development/desa/population/events/other/10/index.shtml UR - http://www.un.org/en/development/desa/population/events/other/10/index.shtml ID - ref1 ER - TY - STD TI - Alwan A, Armstrong T, Cowan M, Riley L, World Health Organization. Noncommunicable diseases country profiles: World Health Organization; 2011. https://www.who.int/nmh/publications/ncd_profiles2011/en/ UR - https://www.who.int/nmh/publications/ncd_profiles2011/en/ ID - ref2 ER - TY - STD TI - World Health Organization. Measuring medicine prices, availability, affordability and price components: World Health Organization; 2008. https://www.who.int/medicines/areas/access/medicines_prices08/en/ UR - https://www.who.int/medicines/areas/access/medicines_prices08/en/ ID - ref3 ER - TY - JOUR AU - Zarocostas, J. PY - 2011 DA - 2011// TI - World’s poorest countries can improve access to medicines through local production, says United Nations JO - Br Med J VL - 342 UR - https://doi.org/10.1136/bmj.d3101 DO - 10.1136/bmj.d3101 ID - Zarocostas2011 ER - TY - BOOK PY - 2015 DA - 2015// TI - Investment opportunity in the pharmaceutical sector in Ethiopia PB - Federal Democratic Republic of Ethiopia CY - Addis Ababa ID - ref5 ER - TY - JOUR AU - Kesselheim, A. S. AU - Misono, A. S. AU - Lee, J. L. PY - 2008 DA - 2008// TI - Clinical equivalence of generic and brand-name drugs used in cardiovascular disease: a systematic review and meta-analysis JO - JAMA VL - 300 UR - https://doi.org/10.1001/jama.2008.758 DO - 10.1001/jama.2008.758 ID - Kesselheim2008 ER - TY - STD TI - World Health Organization. An assessment of medicines regulatory systems in Sub-Saharan African countries: an overview of findings from 26 assessment reports: World Health Organization; 2010. http://apps.who.int/medicinedocs/documents/s17577en/s17577en.pdf UR - http://apps.who.int/medicinedocs/documents/s17577en/s17577en.pdf ID - ref7 ER - TY - JOUR AU - Videau, J. -. Y. PY - 2000 DA - 2000// TI - Generic drugs: the hidden issues of quality and cost JO - WHO Drug Inf VL - 14 ID - Videau2000 ER - TY - JOUR AU - Suleman, S. AU - Woliyi, A. AU - Woldemichael, K. PY - 2016 DA - 2016// TI - Pharmaceutical regulatory framework in Ethiopia: a critical evaluation of its legal basis and implementation JO - Ethiop J Health Sci VL - 26 UR - https://doi.org/10.4314/ejhs.v26i3.9 DO - 10.4314/ejhs.v26i3.9 ID - Suleman2016 ER - TY - JOUR AU - Chen, M. -. L. AU - Shah, V. AU - Patnaik, R. PY - 2001 DA - 2001// TI - Bioavailability and bioequivalence: an FDA regulatory overview JO - Pharm Res VL - 18 UR - https://doi.org/10.1023/A:1013319408893 DO - 10.1023/A:1013319408893 ID - Chen2001 ER - TY - STD TI - Marketing authorization of pharmaceutical products with special reference to multisource (generic) products: a manual for a drug regulatory authority. World Health Organization; 1999. https://apps.who.int/iris/handle/10665/65175. UR - https://apps.who.int/iris/handle/10665/65175 ID - ref11 ER - TY - STD TI - WHO Expert Committee on Specifications for Pharmaceutical Preparations: thirty-fourth report. World Health Organization; 1996. https://apps.who.int/medicinedocs/en/d/Js5516e/. UR - https://apps.who.int/medicinedocs/en/d/Js5516e/ ID - ref12 ER - TY - STD TI - Food Medicine and Health Care Administration and Control Authority. Guidline for registration of medicines: Food Medicine and Health Care Administration and Control Authority; 2014. http://apps.who.int/medicinedocs/documents/s23058en/s23058en.pdf UR - http://apps.who.int/medicinedocs/documents/s23058en/s23058en.pdf ID - ref13 ER - TY - STD TI - Ethiopian Food Medicine and Health Adminstration and Control Authority. Pharmacovigalance report: Ethiopian Food Medicine and Health Adminstration and Control Authority; 2010. Accessed Mar 2016 at http://www.fmhaca.gov.et/pharmacovigilancenewsletter.html UR - http://www.fmhaca.gov.et/pharmacovigilancenewsletter.html ID - ref14 ER - TY - BOOK AU - Sahile, M. PY - 2014 DA - 2014// TI - Pharmacy personnel in Hawassa, a facility based cross sectional study PB - Addis Ababa University Addis Ababa, Ethiopia CY - Addis Ababa ID - Sahile2014 ER - TY - JOUR AU - Hassali, M. A. AU - Wong, Z. Y. PY - 2015 DA - 2015// TI - Challenges of developing generics substitution policies in low-and middle-income countries (LMICs) JO - GaBI J VL - 4 UR - https://doi.org/10.5639/gabij.2015.0404.038 DO - 10.5639/gabij.2015.0404.038 ID - Hassali2015 ER - TY - STD TI - European Generic Medicines Association. Market review – European generic medicines markets: policy overview: European Generic Medicines Association; 2011. https://www.medicinesforeurope.com/wp-content/uploads/2016/11/Market-Review-2016-Generic-medicines-policies.pdf UR - https://www.medicinesforeurope.com/wp-content/uploads/2016/11/Market-Review-2016-Generic-medicines-policies.pdf ID - ref17 ER - TY - JOUR AU - Hassali, M. A. AU - Kong, D. C. AU - Stewart, K. PY - 2006 DA - 2006// TI - Generic medicines: perceptions of general practitioners in Melbourne, Australia JO - J Generic Med VL - 3 UR - https://doi.org/10.1057/palgrave.jgm.4940122 DO - 10.1057/palgrave.jgm.4940122 ID - Hassali2006 ER - TY - JOUR AU - Barrett, L. PY - 2005 DA - 2005// TI - Physicians’ attitudes and practices regarding generic drugs JO - Gerontologist VL - 45 ID - Barrett2005 ER - TY - JOUR AU - Pereira, J. A. AU - Holbrook, A. M. AU - Dolovich, L. PY - 2005 DA - 2005// TI - Are brand-name and generic warfarin interchangeable? Multiple n-of-1 randomized, crossover trials JO - Ann Pharmacother VL - 39 UR - https://doi.org/10.1345/aph.1G003 DO - 10.1345/aph.1G003 ID - Pereira2005 ER - TY - JOUR AU - Kumar, T. P. PY - 2017 DA - 2017// TI - GDUFA–a backbone of Generic’s JO - Imp J Interdiscip Res VL - 3 ID - Kumar2017 ER - TY - BOOK AU - Zou, P. AU - Lawrence, X. Y. PY - 2014 DA - 2014// TI - Pharmacodynamic endpoint bioequivalence studies. FDA bioequivalence standards PB - Springer CY - Netherland ID - Zou2014 ER - TY - BOOK AU - Wang, D. AU - Bakhai, A. PY - 2006 DA - 2006// TI - Clinical trials: a practical guide to design, analysis, and reporting PB - Wiley CY - United States ID - Wang2006 ER - TY - CHAP AU - Peabody, J. W. AU - Taguiwalo, M. M. AU - Robalino, D. A. AU - Frenk, J. PY - 2006 DA - 2006// TI - Improving the quality of care in developing countries BT - Disease control priorities in developing countries ID - Peabody2006 ER - TY - JOUR AU - McGlynn, E. A. AU - Asch, S. M. AU - Adams, J. PY - 2003 DA - 2003// TI - The quality of health care delivered to adults in the United States JO - N Engl J Med VL - 348 UR - https://doi.org/10.1056/NEJMsa022615 DO - 10.1056/NEJMsa022615 ID - McGlynn2003 ER - TY - JOUR AU - Supratikto, G. AU - Wirth, M. E. AU - Achadi, E. AU - Cohen, S. AU - Ronsmans, C. PY - 2002 DA - 2002// TI - A district-based audit of the causes and circumstances of maternal deaths in South Kalimantan, Indonesia JO - Bull World Health Organ VL - 80 ID - Supratikto2002 ER - TY - JOUR AU - Leatherman, S. AU - Ferris, T. G. AU - Berwick, D. AU - Omaswa, F. AU - Crisp, N. PY - 2010 DA - 2010// TI - The role of quality improvement in strengthening health systems in developing countries JO - Int J Qual Health Care VL - 22 UR - https://doi.org/10.1093/intqhc/mzq028 DO - 10.1093/intqhc/mzq028 ID - Leatherman2010 ER - TY - STD TI - MClellan MB. Improving health care quality: the path forward. Center for Health Policy (ed.): Brookings Institution; 2013. http://www.brookings.edu/research/testimony/2013/06/26-improving-health-care-quality-mcclellan: Congressional Testimony UR - http://www.brookings.edu/research/testimony/2013/06/26-improving-health-care-quality-mcclellan ID - ref28 ER - TY - JOUR AU - Guyatt, G. AU - Sackett, D. AU - Taylor, D. W. AU - Ghong, J. AU - Roberts, R. AU - Pugsley, S. PY - 1986 DA - 1986// TI - Determining optimal therapy—randomized trials in individual patients JO - N Engl J Med VL - 314 UR - https://doi.org/10.1056/NEJM198604033141406 DO - 10.1056/NEJM198604033141406 ID - Guyatt1986 ER - TY - BOOK AU - Kravitz, R. AU - Duan, N. PY - 2014 DA - 2014// TI - Design and implementation of N-of-1 trials: a user’s guide PB - Agency for healthcare research and quality, US Department of Health and Human Services CY - United States ID - Kravitz2014 ER - TY - BOOK AU - Nikles, J. AU - Mitchell, G. PY - 2015 DA - 2015// TI - The essential guide to N-of-1 trials in health PB - Springer CY - Netherland UR - https://doi.org/10.1007/978-94-017-7200-6 DO - 10.1007/978-94-017-7200-6 ID - Nikles2015 ER - TY - JOUR AU - Pollak, P. PY - 2010 DA - 2010// TI - Therapeutically relevant blood pressure differences with two nifedipine (60 mg) osmotic delivery systems of differing design: three case reports JO - Int J Clin Pharmacol Ther VL - 48 UR - https://doi.org/10.5414/CPP48400 DO - 10.5414/CPP48400 ID - Pollak2010 ER - TY - JOUR AU - Ayala, G. X. AU - Elder, J. P. AU - Campbell, N. R. PY - 2001 DA - 2001// TI - Nutrition communication for a Latino community: formative research foundations JO - Fam Community Health VL - 24 UR - https://doi.org/10.1097/00003727-200110000-00009 DO - 10.1097/00003727-200110000-00009 ID - Ayala2001 ER - TY - JOUR AU - Boote, J. AU - Telford, R. AU - Cooper, C. PY - 2002 DA - 2002// TI - Consumer involvement in health research: a review and research agenda JO - Health Policy VL - 61 UR - https://doi.org/10.1016/S0168-8510(01)00214-7 DO - 10.1016/S0168-8510(01)00214-7 ID - Boote2002 ER - TY - JOUR AU - Wells, M. AU - Williams, B. AU - Treweek, S. AU - Coyle, J. AU - Taylor, J. PY - 2012 DA - 2012// TI - Intervention description is not enough: evidence from an in-depth multiple case study on the untold role and impact of context in randomised controlled trials of seven complex interventions JO - Trials VL - 13 UR - https://doi.org/10.1186/1745-6215-13-95 DO - 10.1186/1745-6215-13-95 ID - Wells2012 ER - TY - JOUR AU - O’Cathain, A. AU - Hoddinott, P. AU - Lewin, S. PY - 2015 DA - 2015// TI - Maximising the impact of qualitative research in feasibility studies for randomised controlled trials: guidance for researchers JO - Pilot Feasibility Stud VL - 1 UR - https://doi.org/10.1186/s40814-015-0026-y DO - 10.1186/s40814-015-0026-y ID - O’Cathain2015 ER - TY - BOOK AU - Bartholomew, L. AU - Parcel, G. AU - Kok, G. AU - Gottlieb, N. PY - 2006 DA - 2006// TI - Planning health promotion programs: intervention mapping PB - Wiley and Jossey-Bass CY - United States ID - Bartholomew2006 ER - TY - JOUR AU - Bernal, G. PY - 2006 DA - 2006// TI - Intervention development and cultural adaptation research with diverse families JO - Fam Process VL - 45 UR - https://doi.org/10.1111/j.1545-5300.2006.00087.x DO - 10.1111/j.1545-5300.2006.00087.x ID - Bernal2006 ER - TY - JOUR AU - Whitehead, A. L. AU - Sully, B. G. AU - Campbell, M. J. PY - 2014 DA - 2014// TI - Pilot and feasibility studies: is there a difference from each other and from a randomised controlled trial? JO - Contemp Clin Trials VL - 38 UR - https://doi.org/10.1016/j.cct.2014.04.001 DO - 10.1016/j.cct.2014.04.001 ID - Whitehead2014 ER - TY - BOOK AU - Richards, D. A. AU - Hallberg, I. R. PY - 2015 DA - 2015// TI - Complex interventions in health: an overview of research methods PB - Routledge CY - British UR - https://doi.org/10.4324/9780203794982 DO - 10.4324/9780203794982 ID - Richards2015 ER - TY - JOUR AU - Alemayehu, C. AU - Mitchell, G. AU - Nikles, J. AU - Aseffa, A. AU - Clavarino, A. PY - 2018 DA - 2018// TI - Views and perceptions about locally manufactured medicines in Ethiopia: a qualitative study of physicians, patients and regulatory authorities JO - BMC Health Serv Res VL - 18 UR - https://doi.org/10.1186/s12913-018-3410-5 DO - 10.1186/s12913-018-3410-5 ID - Alemayehu2018 ER - TY - STD TI - Ritchie J, Spencer L. Analysing qualitative data. Chapter 9, Qualitative data analysis for applied policy research. California: SAGE Publications, Inc. 2002. p. 305–29. ID - ref42 ER - TY - BOOK PY - 2010 DA - 2010// TI - Guideline for conducting clinical trials in Ethiopia ID - ref43 ER - TY - JOUR AU - Garuba, H. A. AU - Kohler, J. C. AU - Huisman, A. M. PY - 2009 DA - 2009// TI - Transparency in Nigeria’s public pharmaceutical sector: perceptions from policy makers JO - Glob Health VL - 5 UR - https://doi.org/10.1186/1744-8603-5-14 DO - 10.1186/1744-8603-5-14 ID - Garuba2009 ER - TY - JOUR AU - Kravitz, R. L. AU - Duan, N. AU - Niedzinski, E. J. AU - Hay, M. C. AU - Subramanian, S. K. AU - Weisner, T. S. PY - 2008 DA - 2008// TI - What ever happened to N-of-1 trials? Insiders’ perspectives and a look to the future JO - Milbank Q VL - 86 UR - https://doi.org/10.1111/j.1468-0009.2008.00533.x DO - 10.1111/j.1468-0009.2008.00533.x ID - Kravitz2008 ER - TY - JOUR AU - Gabler, N. B. AU - Duan, N. AU - Vohra, S. AU - Kravitz, R. L. PY - 2011 DA - 2011// TI - N-of-1 trials in the medical literature: a systematic review JO - Med Care VL - 49 UR - https://doi.org/10.1097/MLR.0b013e318215d90d DO - 10.1097/MLR.0b013e318215d90d ID - Gabler2011 ER - TY - JOUR AU - Cen, R. AU - Hussain, A. AU - Pak, K. J. PY - 2016 DA - 2016// TI - Do N-of-1 trials need IRB review? JO - J Empir Res Hum Res Ethics VL - 11 UR - https://doi.org/10.1177/1556264616662560 DO - 10.1177/1556264616662560 ID - Cen2016 ER - TY - STD TI - Ethiopian Ministry of Health and Science Technology. National research ethics review guideline: Ethiopian Ministry of Health and Science Technology; 2014. https://www.ccghr.ca/wp-content/uploads/2013/11/national-research-ethics-review-guidline.pdf UR - https://www.ccghr.ca/wp-content/uploads/2013/11/national-research-ethics-review-guidline.pdf ID - ref48 ER - TY - JOUR AU - Nikles, J. AU - Mitchell, G. K. AU - Clavarino, A. AU - Yelland, M. J. AU - Mar, C. B. PY - 2010 DA - 2010// TI - Stakeholders’ views on the routine use of n-of-1 trials to improve clinical care and to make resource allocation decisions for drug use JO - Aust Health Rev VL - 34 UR - https://doi.org/10.1071/AH09654 DO - 10.1071/AH09654 ID - Nikles2010 ER -